About

Longevity.Group

The operating group behind the portfolio

Longevity.Group builds and operates the ventures, platforms and intelligence institutions that make longevity medicine deliverable at scale — from clinical infrastructure and management systems to regional intelligence and flagship developments.

What Longevity.Group is

The parent, not one of the projects

This distinction matters. Longevity Club, the Gulf Longevity Intelligence Group and the Dubai Longevity Constellation are each sub-projects of Longevity.Group — not the group itself.

The operating group

Longevity.Group holds and operates the portfolio, sets direction and supplies shared infrastructure across every venture.

Twelve projects

Membership, financial infrastructure, management systems, flagship developments, intelligence institutions, habitats and devices — each with its own team, roadmap and market.

One operating system

Every project is a component of a single end-to-end Longevity Operating System — intelligence, protocols, blueprints, delivery and measurement, designed to work together.

The structure

How the group fits together

Longevity.GroupThe operating group — direction, shared infrastructure, capital

Gulf Longevity Intelligence Group

The regional intelligence institution for the Gulf longevity ecosystem.

Longevity Club

The membership platform and clinic network access layer.

Dubai Longevity Constellation

The flagship development programme.

Management systems

LBams and API-AMS — hospital and procurement infrastructure.

Gulf Longevity Intelligence Group

Our regional intelligence institution

GLIG is positioned as an intelligence institution rather than a media, consulting or research company — built to serve as the decision layer of the Gulf longevity ecosystem.

Gulf Longevity Intelligence Group
Ecosystem intelligence — mapping the companies, investors, institutions and regulators of the Gulf longevity sector
Rankings and market maps — published intelligence on the region’s leading organisations and capital flows
Regulatory tracking — developments across GCC health and innovation authorities
Decision support — for government bodies, investors, corporates and operators entering the region
The organising principle

An end-to-end Longevity Operating System

Every project in the group is a component of one system. That is the whole design: not a collection of ventures that happen to share an owner, but an operating system running from intelligence at one end to measured clinical outcome at the other.

01

Intelligence layer

Map the entire field. Who is building what, what is funded, what is regulated, and what is merely announced. The database, the frameworks and the monitoring that make the industry legible.

02

Evidence layer

Separate what works from what is marketed. A decade of scientific due diligence isolating the modalities with genuine human validation from everything surrounding them.

03

Protocol layer

Turn validated modalities into defined, repeatable clinical protocols — composition, dosing, sequencing, contraindications and measurement.

04

Blueprint layer

Turn protocols into deployable facilities. Use-case-specific clinical blueprints covering equipment, layout, staffing and patient pathway.

05

Delivery layer

Build and operate. Clinics, modular units, membership platforms and the digital infrastructure that runs them.

06

Measurement layer

Capture what happens. Outcomes feed back into the evidence layer, and the system improves with every cycle.

Nobody else holds the whole chainAnalysts hold the intelligence layer. Clinics hold delivery. Device makers hold one modality. Longevity.Group holds all six layers and operates them as a single system — which is why an insight at the intelligence layer can become a deployed protocol rather than a published observation.
How this was built

A decade, in four movements

From 2014

Defining a field that had no definition

Longevity was a research interest, not an industry. There was no classification, no map, no way to tell a serious company from an announcement. We built the first frameworks to make it analysable, and the first comprehensive database of who was actually in it.

2015 onward

Building the operational intelligence architecture

Mapping a field once is a report. Mapping it continuously is infrastructure. We built the tech stacks, monitoring methods and benchmarking systems to track every significant player, technology and capital movement — and kept them running for ten years.

Throughout

Separating what works from what is marketed

The hardest and least glamorous work: a decade of scientific due diligence establishing which modalities have genuine human evidence behind them. Much of what the field promotes does not survive that filter. What does became the foundation of everything we build.

By 2025

Density that required its own house

Protocols, clinical blueprints, digital infrastructure, management systems and an exclusive holding of validated modalities had accumulated into something that could no longer sit inside a research group. Longevity.Group was established to hold, structure and operate it.

Where this comes from

Active in longevity since 2014

Deep Knowledge Group and its longevity projects have been building in this field for over a decade. Longevity.Group exists because those assets reached a density that needed its own house.

We were the first

To define the longevity industry and its frameworks

Before the classification system existed, there was no way to compare one company to another or one modality to another. We built them.

To map, profile and systematise the whole industry

Not a survey but a living record — the first and largest global longevity ecosystem database, platform and dashboard maintained continuously since inception.

To unify all of longevity

The Longevity Constitution brings the field’s fragmented parts into a single coherent structure for the first time.

What we exclusively hold

Longevity Medicine 2.0

Advanced practical mitochondrial-medicine modalities, several originating in space medicine programmes, combined with the protocols, blueprints and digital infrastructure to deploy them.

The evidence filter itself

Ten years of due diligence separating human-validated modalities from the rest. The filter is as valuable as anything it has selected.

The research beyond 120 years

Pioneering work aimed at passing the current limit of human lifespan.

The operating principle

What actually makes the group different

01

Operational intelligence first

A decade of deep ecosystem mapping, monitoring and benchmarking of every major player — the tech stacks, the methods and the databases that make the field legible.

02

Evidence over hype

Ten years of scientific due diligence separating what has genuine human evidence from what does not. Everything we build sits on that filter.

03

We build what we analyse

Analysis became protocols, protocols became blueprints, blueprints became management systems. LBams and API-AMS are the first and only of their kind.

04

Structured to compound

By 2025 these assets reached a density that required its own house. Longevity.Group is that house — holding, operating and compounding them.

What the group holds

Assets, not just ambitions

Ecosystem intelligence

The first and largest global longevity industry database, platform and dashboard — with the classification frameworks originally created to analyse the field.

Longevity Medicine 2.0

Protocols and clinical blueprints developed on the evidence base, with the delivery infrastructure to put them into practice.

LBams and API-AMS

Blueprint configuration and procurement infrastructure that starts nowhere else. LBams turns clinical intent into a specified, costed, buildable facility; API-AMS turns that specification into an executable implementation pathway.

Digital and virtual infrastructure

The platforms, dashboards and applications through which the group’s assets are delivered and measured.

The portfolio

Twelve projects across six domains

Each operates under Longevity.Group with its own team and market. Open any project to see the detail.

Engage

Work with Longevity.Group

Partnership, investment, clinical collaboration or market entry — tell us which project is relevant and we will route you to the right team.